| 臺大學術典藏 |
2018-09-10T04:06:34Z |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Liaw, S.-J. and Teng, L.-J. and Hsueh, P.-R. and Ho, S.-W. and Luh, K.-T.; PO-REN HSUEH |
| 國立臺灣大學 |
2002-07 |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Liaw, SJ; Teng, LJ; Hsueh, PR; Ho, SW; Luh, KT. |
| 臺大學術典藏 |
2020-03-27T05:31:05Z |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Luh K.-T.; PO-REN HSUEH; Ho S.-W.; Teng L.-J.; Liaw S.-J.; Luh K.-T.;Ho S.-W.;PO-REN HSUEH;Teng L.-J.;Liaw S.-J. |
| 臺大學術典藏 |
2002 |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Liaw S.-J.; LEE-JENE TENG; Hsueh P.-R.; Ho S.-W.; Luh K.-T.; Liaw S.-J.;Lee-Jene Teng;Hsueh P.-R.;Ho S.-W.;Luh K.-T. |
| 臺大學術典藏 |
2020-07-01T08:45:22Z |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Shwu-Jen Liaw;Teng L.-J.;Hsueh P.-R.;Ho S.-W.;Luh K.-T.; SHWU-JEN LIAW; Teng L.-J.; Hsueh P.-R.; Ho S.-W.; Luh K.-T. |
| 嘉南藥理大學 |
2023 |
In vitro activities of antimicrobial combinations against planktonic and biofilm forms of Stenotrophomonas maltophilia
|
Su, Bo-An; Chen, Chi-Chung; Chen, Hung-Jui; Lai, Hsin-Yu; Tsai, Chia-Hung; Lai, Chih-Cheng; Tang, Hung-Jen; Chao, Chien-Ming |
| 臺北醫學大學 |
2004 |
In Vitro activities of B-lactam antibiotics alone and in combination with sulbactam against gram-negative bacteriae
|
李文生; Wang FD; Lin ML; Lee WS; Liu CY |
| 臺大學術典藏 |
2020-03-27T05:28:25Z |
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
|
PO-REN HSUEH; Liao C.-H.; Tsuji M.; Huang Y.-T.; Lee Y.-J.; Hsueh S.-C.; PO-REN HSUEH;Tsuji M.;Liao C.-H.;Huang Y.-T.;Lee Y.-J.;Hsueh S.-C. |
| 臺大學術典藏 |
2020-12-18T08:37:00Z |
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
|
Hsueh S.-C.;Lee Y.-J.;Huang Y.-T.;Liao C.-H.;Tsuji M.;Po-Ren Hsueh; Hsueh S.-C.; Lee Y.-J.; Huang Y.-T.; Liao C.-H.; Tsuji M.; PO-REN HSUEH |
| 臺大學術典藏 |
2021-05-18T05:56:32Z |
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
|
Hsueh S.-C.; Lee Y.-J.; YU-TSUNG HUANG; Liao C.-H.; Tsuji M.; Hsueh P.-R. |
| 國立成功大學 |
2023 |
In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveil
|
Lee, Y.-L.;Ko, W.-C.;Hsueh, P.-R. |
| 臺大學術典藏 |
2018-09-10T08:05:53Z |
In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: Nationwide data from the SMART Programme
|
Jean, S.-S. and Hsueh, P.-R. and Lee, W.-S. and Chang, H.-T. and Chou, M.-Y. and Chen, I.-S. and Wang, J.-H. and Lin, C.-F. and Shyr, J.-M. and Ko, W.-C. and Wu, J.-J. and Liu, Y.-C. and Huang, W.-K. and Teng, L.-J. and Liu, C.-Y.; PO-REN HSUEH; LEE-JENE TENG |
| 臺大學術典藏 |
2020-03-27T05:29:58Z |
In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: Nationwide data from the SMART Programme
|
Liu C.-Y.; Teng L.-J.; Huang W.-K.; Liu Y.-C.; Liu C.-Y.;Teng L.-J.;Huang W.-K.;Liu Y.-C.;Wu J.-J.;Ko W.-C.;Shyr J.-M.;Lin C.-F.;Wang J.-H.;Chen I.-S.;Chou M.-Y.;Chang H.-T.;Lee W.-S.;PO-REN HSUEH;Jean S.-S.; Jean S.-S.; PO-REN HSUEH; Lee W.-S.; Chang H.-T.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J. |
| 臺大學術典藏 |
2020-06-30T06:13:31Z |
In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: Nationwide data from the SMART Programme
|
Jean S.-S.;Hsueh P.-R.;Lee W.-S.;Chang H.-T.;Chou M.-Y.;Chen I.-S.;Wang J.-H.;Lin C.-F.;Shyr J.-M.;Ko W.-C.;Wu J.-J.;Liu Y.-C.;Huang W.-K.;Lee-Jene Teng;Liu C.-Y.; Jean S.-S.; Hsueh P.-R.; Lee W.-S.; Chang H.-T.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; LEE-JENE TENG; Liu C.-Y. |
| 臺大學術典藏 |
2010 |
In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: Nationwide data from the SMART Programme
|
Wang J.-H.; Chen I.-S.; Chou M.-Y.; Chang H.-T.; Lee W.-S.; PO-REN HSUEH; Jean S.-S.; Jean S.-S.;Po-Ren Hsueh;Lee W.-S.;Chang H.-T.;Chou M.-Y.;Chen I.-S.;Wang J.-H.;Lin C.-F.;Shyr J.-M.;Ko W.-C.;Wu J.-J.;Liu Y.-C.;Huang W.-K.;Teng L.-J.;Liu C.-Y.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; Teng L.-J.; Liu C.-Y. |
| 臺北醫學大學 |
2008 |
In Vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over ten years.
|
劉永慶; Huang TS; Liu YC; Sy CL; Chen YS; Tu HZ; Chen BC |
| 國立臺灣大學 |
2009 |
In Vitro Activities of Moxifloxacin and Tigecycline against Bacterial Isolates Associated with Intraabdominal Infections at a Medical Center in Taiwan, 2001-2006
|
劉佳穎; 路景蘭; 黃昱璁; 廖俊星; 薛博仁; LIU, CHIA-YING; LU, CHING-LAN; HUANG, YU- TSUNG; LIAO, CHUN-HSIN; HSUEH, PO-REN |
| 臺大學術典藏 |
2018-09-10T07:24:02Z |
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006
|
Liu, C.-Y. and Lu, C.-L. and Huang, Y.-T. and Liao, C.-H. and Hsueh, P.-R.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-03-27T05:30:04Z |
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006
|
PO-REN HSUEH; Liao C.-H.; PO-REN HSUEH;Liao C.-H.;Huang Y.-T.;Lu C.-L.;Liu C.-Y.; Liu C.-Y.; Lu C.-L.; Huang Y.-T. |
| 臺大學術典藏 |
2020-12-18T08:38:50Z |
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006
|
Liu C.-Y.; Lu C.-L.; Huang Y.-T.; Liao C.-H.; PO-REN HSUEH |
| 臺大學術典藏 |
2021-05-18T05:57:10Z |
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006
|
Liu C.-Y.; Lu C.-L.; YU-TSUNG HUANG; Liao C.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-08-20T08:50:16Z |
In vitro activities of piperacillin or cefoperazone alone and in combination with β-lactamase inhibitors against Gram-negative bacilli
|
HAN-YUEH KUO; Wang F.-D.; Yen Y.-F.; Lin M.-L.; Liu C.-Y. |
| 國立臺灣大學 |
2015 |
In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia
|
Chen, Ko-Hung; Huang, Yu-Tsung; Liao, Chun-Hsing; Sheng, Wang-Hui; Hsueh, Po-Ren; 薛博仁; 盛望徽 |
| 臺大學術典藏 |
2021-02-26T01:59:38Z |
In vitro activities of tedizolid and linezolid against Gram-positive cocci associated with acute bacterial skin and skin structure infections and pneumonia
|
Chen K.-H.;Huang Y.-T.;Liao C.-H.;Wang-Huei Sheng;Hsuehd P.-R.; Chen K.-H.; Huang Y.-T.; Liao C.-H.; WANG-HUEI SHENG; Hsuehd P.-R. |
| 臺大學術典藏 |
2021-05-18T05:56:39Z |
In vitro activities of tedizolid and linezolid against Gram-positive cocci associated with acute bacterial skin and skin structure infections and pneumonia
|
Chen K.-H.; YU-TSUNG HUANG; Liao C.-H.; Sheng W.-H.; Hsuehd P.-R. |
| 國立臺灣海洋大學 |
2009-06 |
In vitro activities of three synthetic peptides derived from epinecidin-1 and an anti-lipopolysaccharide factor against Propionibacterium acnes, Candida albicans, and Trichomonas vaginalis
|
Chieh-Yu Pan;Jyh-Yih Chen;Tai-Lang Lin;Cheng-Hui Lin |
| 國立臺灣大學 |
2008 |
In Vitro Activities of Tigecycline against Clinical Isolates of Aeromonas , Vibrio, and Salmonella Species in Taiwan
|
劉佳穎; 黃昱璁; 廖俊星; 薛博仁; LIU, CHIA-YING; HUANG, YU-TSUNG; LIAO, CHUN-HSIN; HSUEH, PO-REN |
| 臺大學術典藏 |
2019-07-24T12:39:09Z |
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan
|
PO-REN HSUEH;Liao, Chun-Hsing;Huang, Yu-Tsung;Liu, Chia-Ying; Liu, Chia-Ying; Huang, Yu-Tsung; Liao, Chun-Hsing; PO-REN HSUEH |
| 臺大學術典藏 |
2020-03-27T05:30:19Z |
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan
|
PO-REN HSUEH; Liao C.-H.; Liu C.-Y.; Huang Y.-T.; PO-REN HSUEH;Liao C.-H.;Huang Y.-T.;Liu C.-Y. |
| 臺大學術典藏 |
2021-05-18T05:57:18Z |
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan
|
Liu C.-Y.; YU-TSUNG HUANG; Liao C.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2020-12-18T08:39:08Z |
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan
|
PO-REN HSUEH; Liao C.-H.; Huang Y.-T.; Liu C.-Y. |
| 國立臺灣大學 |
2005-12 |
In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan
|
Cheng, NC; Hsueh; Liu, YC; Shyr, JM; Huang, WK; Teng, LJ; Liu, CY |
| 臺大學術典藏 |
2018-09-10T05:13:56Z |
In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan
|
Cheng, N.-C. and Hsueh, P.-R. and Liu, Y.-C. and Shyr, J.-M. and Huang, W.-K. and Teng, L.-J. and Liu, C.-Y.; PO-REN HSUEH; LEE-JENE TENG |
| 臺大學術典藏 |
2005 |
In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan
|
Liu C.-Y.; Teng L.-J.; Liu C.-Y.;Teng L.-J.;Huang W.-K.;Shyr J.-M.;Liu Y.-C.;PO-REN HSUEH;Cheng N.-C.; Cheng N.-C.; PO-REN HSUEH; Liu Y.-C.; Shyr J.-M.; Huang W.-K. |
| 臺大學術典藏 |
2020-06-30T06:13:40Z |
In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan
|
Cheng N.-C.;Hsueh P.-R.;Liu Y.-C.;Shyr J.-M.;Huang W.-K.;Lee-Jene Teng;Liu C.-Y.; Cheng N.-C.; Hsueh P.-R.; Liu Y.-C.; Shyr J.-M.; Huang W.-K.; LEE-JENE TENG; Liu C.-Y. |
| 臺大學術典藏 |
2020-12-18T08:39:36Z |
In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan
|
Cheng N.-C.;Po-Ren Hsueh;Liu Y.-C.;Shyr J.-M.;Huang W.-K.;Teng L.-J.;Liu C.-Y.; Cheng N.-C.; PO-REN HSUEH; Liu Y.-C.; Shyr J.-M.; Huang W.-K.; Teng L.-J.; Liu C.-Y. |
| 臺北醫學大學 |
2005 |
In Vitro activities of tigecycline, ertapenem,isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan.
|
劉永慶; Cheng NC; Hsueh PR; Liu YC; Shyr JM; Huang WK; Teng LJ; Liu CY |
| 國立成功大學 |
2007-02 |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data
|
Hung, Min-Nan; Hsueh, Po-Ren; Chang, Hou-Tai; Lee, Wen-Sen; Chou, Ming-Yuan; Chen, Ing-Shen; Wang, Jen-Hsien; Lin, Chen-Fu; Shyr, Jainn-Ming; Ko, Wen-Chien; Wu, Jiunn-Jong; Liu, Yung-Ching; Huang, Wen-Kuei; Teng, Lee-Jene; Liu, Cheng-Yi; Luh, Kwen-Tay |
| 國立臺灣大學 |
2007 |
In Vitro Activities of Various Piperacillin and Sulbactam Combinations against Bacterial Pathogens Isolated from Intensive Care Units in Taiwan: Smart 2004 Programme Data
|
洪敏南; 薛博仁; 張厚台; 周明淵; 王任賢; 石建民; 柯文謙; 吳俊忠; 劉永慶; 黃文貴; 鄧麗珍; 劉正義; 陸坤泰; HUNG, MIN-NAN; HSUEH, PO-REN; CHANG, HOU- TAI; CHOU, MING-YUAN; WANG, JEN-HSIEN; SHYR, JAINN-MING; KO, WEN-CHIEN; WU, JIUNN-JONG; LIU, YUNG-CHIN; HUANG, WEN-KUEI; TENG, LEE-JENE; LIU, CHENG-YI; LUH, KWEN-TAY |
| 臺大學術典藏 |
2018-09-10T06:16:32Z |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data
|
Hung, M.-N. and Hsueh, P.-R. and Chang, H.-T. and Lee, W.-S. and Chou, M.-Y. and Chen, I.-S. and Wang, J.-H. and Lin, C.-F. and Shyr, J.-M. and Ko, W.-C. and Wu, J.-J. and Liu, Y.-C. and Huang, W.-K. and Teng, L.-J. and Liu, C.-Y. and Luh, K.-T.; PO-REN HSUEH; LEE-JENE TENG |
| 臺大學術典藏 |
2020-03-27T05:30:29Z |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data
|
Chang H.-T.; Lee W.-S.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; Teng L.-J.; Liu C.-Y.; Luh K.-T.; PO-REN HSUEH; Hung M.-N.; Luh K.-T.;Liu C.-Y.;Teng L.-J.;Huang W.-K.;Liu Y.-C.;Wu J.-J.;Ko W.-C.;Shyr J.-M.;Lin C.-F.;Wang J.-H.;Chen I.-S.;Chou M.-Y.;Lee W.-S.;Chang H.-T.;PO-REN HSUEH;Hung M.-N. |
| 臺大學術典藏 |
2020-12-18T08:39:20Z |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data
|
Luh K.-T.; Liu C.-Y.; Teng L.-J.; Huang W.-K.; Liu Y.-C.; Wu J.-J.; Ko W.-C.; Shyr J.-M.; Lin C.-F.; Wang J.-H.; Hung M.-N.; PO-REN HSUEH; Chang H.-T.; Lee W.-S.; Chou M.-Y.; Chen I.-S. |
| 臺大學術典藏 |
2021-05-26T03:34:53Z |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data
|
Hung M.-N.; Hsueh P.-R.; Chang H.-T.; Lee W.-S.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; Teng L.-J.; Liu C.-Y.; KWEN-TAY LUH |
| 臺北醫學大學 |
2007 |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from intensive care units in Taiwan: SMART 2004 programme data.
|
李文生; Hung MN; Hsueh PR; Chang HT; Lee WS; Chou MY; Chen IS; Wang JH; Lin CF; Shyr JM; Ko WC; Wu JJ; Liu YC; Huang WK; Teng LJ; Liu CY; Luh KT |
| 臺北醫學大學 |
2007 |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from intensive care units in Taiwan: SMART 2004 programme data.
|
劉永慶; Hung MN; Hsueh PR; Chang HT; Lee WS; Chou MY; Chen IS; Wang JH; Lin CF; Shyr JM; Ko WC; Wu JJ; Liu YC; Huang WK; Teng LJ; Liu CY; Luh KT |
| 臺北醫學大學 |
2006 |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan:SMART 2004 programme data
|
Min-Nan Hung;Po-Ren Hsueh;Hou-Tai Chang;Wen-Sen Lee;Ming-Yuan Chou;Ing-Shen Chen;Jen-Hsien Wang;Chen-Fu Lin;Jainn-Ming Shyr;Wen-Chien Ko;Jiunn-Jong Wu;Yung-Ching Liu;Wen-Kuei Huang;Lee-Jene Teng;Cheng-Yi Liu;Kwen-Tay Luh |
| 國立臺灣大學 |
1993 |
In Vitro Activity of Antimicrobial Agents, Alone and in Combination, Against Acinetobacter Baumannii Isolated from Blood
|
張上淳; 陳宜君; Luh, K. T.; 謝維銓; 張上淳; 陳宜君; Luh, K. T.; Hsieh, Wei-Chuan |
| 國立臺灣大學 |
2002-12 |
In vitro activity of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Liaw, SJ; Teng, LJ; Ho, SW; Luh, KT; Hsueh, PR. |
| 國家衛生研究院 |
2025-06-04 |
In vitro activity of cefepime-zidebactam, ceftolozane-tazobactam, ceftazidime-avibactam, imipenem-relebactam, and other comparators against imipenem-non-susceptible Pseudomonas aeruginosa in Taiwan, 2022
|
Lee, YL;Tan, MC;Chen, PJ;Shiau, YR;Wang, HY;Lai, JF;Huang, IW;Yang, YS;Kuo, SC |
| 國立成功大學 |
2022 |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodst
|
Liu, P.-Y.;Ko, W.-C.;Lee, W.-S.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Lu, M.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Shao, P.-L.;Lee, Y.-L.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Hsueh, P.-R. |
